Tickets to the Gala are $125.00 each or $1,000 per table of 10 people. You can purchase online or send a check below.
2020 Gala Ticket(s) Purchase
Buy Gala Tickets in Groups of 10 per Table
Checks can be made out to Leocadia, Inc.
2549 Eastbluff Drive B-755
Newport Beach, CA 92660
Y O U A R E I N V I T E D
March to the Beat III
RSVP by February 20, 2020
Date: February 29, 2020: 5-9 PM
Newport Coast Community Center
6401 San Joaquin Hills Road, Newport Beach, CA 92657
Hor D’oeuvres, Dinner, Silent Auction, Speakers, EndoPat Studies, DJ
Professor Juan-Carlos Kaski, DSc, MD, DM
(Hons), FRCP, FESC, FACC, FAHA, FRSM
Professor Kaski is Professor of Cardiovascular Science and Immediate Past Director of the Cardiovascular and Cell Sciences Research Institute at St George’s, University of London. He is Honorary Consultant Cardiologist at St George’s Hospital, and the Royal Brompton Hospital, in London. Professor Kaski is also Past-President of the International Society of Cardiovascular Pharmacotherapy and Editor-in-Chief of European Cardiology Review. His research is focused on mechanisms of angina pectoris and special areas of interest include Coronary Artery Spasm and Coronary Microvascular Dysfunction. Professor Kaski has authored over 500 papers in peer review journals and more than 150 invited papers and book chapters. He has also edited eight books on cardiovascular topics, including the European Society of Cardiology Handbook of Cardiovascular Pharmacotherapy and regularly lectures around the world. Professor Kaski has been involved for many years in raising awareness and furthering education for patients with chest pain and no obstruction to their coronary arteries and is considered to be a world leading authority in the diagnosis and management of angina pectoris. Professor Kaski was the Principal Speaker at the INOCA International 2019 Meeting of Minds held at The Dorchester in London in September 2019.
LEOCADIA is currently raising funds to purchase an EndoPat device from Itamar Medical, the only FDA-cleared device indicated for the diagnosis of Endothelial Dysfunction – the earliest clinically detectable marker of vascular health.
Our goal is to donate the EndoPat to a Women’s Wellness Center and encourage routine heart health screening and early diagnosis.
There will be a representative onsite performing EndoPat studies for a limited number of attendees.
If you are interested in having your individual EndoPat study done, please contact Sue at email@example.com